About Us

We're driven to improve the lives of cancer patients

We are a team of people passionate about reducing preclinical uncertainty in immunotherapy development and improving the lives of cancer patients through our novel platform.

About our company

Cancer continues to be a leading cause of death worldwide, with the number of patients projected to triple by 2060. While advances in immunotherapy are helping to reshape the paradigm, we have yet to realize their full potential—currently only 5-7% make it to market1. And, even once they make it to market, only 1 in 5 patients receiving immunotherapy respond2.

We are working to solve this problem with the only ex vivo platform that uses live tumor fragments to measure response of immunotherapies within the live, native tumor microenvironment. The Elephas platform helps biopharma researchers make informed decisions about an immunotherapy candidate's performance and path forward in development.

Elephas is also revolutionizing immunotherapy response prediction with our clinical diagnostic platform using advanced imaging. 

We are

Our mission is to develop innovative cancer diagnostic products and services that enable accurate prediction of clinical treatment outcomes and accelerate drug development

  • Passionate about improving the lives of cancer patients
  • Enthusiastic teachers
  • Grounded and gritty

Meet the team

Our Leaders

Maneesh Maneesh K. Arora Founder and Chief Executive Officer
Terry_Brady_NoTie_F Terry Brady Chief Financial Officer
Fred_Hausheer Fred Hausheer, MD, FACP Chief Medical Officer
Erin_cropped_headshot-removebg-preview Erin Kaminsky Vice President, Chief of Staff
Mike S Mike Szulczewski Executive Vice President of Technology
Ann_Leonard Ann Leonard Vice President of Quality & Regulatory
Steve_for_website-removebg-preview Steven Fuhrman Vice President of Software Engineering & IT
Scott_Johnson_3724_F Scott Johnson, PhD Vice President of Research & Development
3678 Hinco J. Gierman, PhD Vice President of Precision Oncology
Charles_Miller Charles Miller, PhD Vice President of Business Development and Strategy
Tammy_for_website-removebg-preview Tammy Turek-Etienne, PhD Vice President of Operations
Kristen_for_website-removebg-preview Kristen Weiler Vice President of Marketing

Our Board of Directors

Maneesh Maneesh K. Arora Founder, CEO, and Board Member
Galson for Website-1 Steven K. Galson, M.D., M.P.H. Board Member
Andrea Jackson for website-3 Andrea Jackson Board Member
Paul Berns for website-1 Paul Berns Board Member

Our Investors

Moore Strategic Ventures LLC
Tao for website-1
SWIB Logo High Res
Venture Investors-RGB-Primary-Full Color

Latest News

Stay up to date on our technology and services.


Join Us

We're always on the lookout for talented individuals to join our team.

References: 1. Zhu AZ. Quantitative translational modeling to facilitate preclinical to clinical efficacy & toxicity translation in oncology. Future Science OA. 2018;4(5):FSO306-FSO306. 2. Chen et al., 2016 Cancer Discovery.